Pfizer Vaccine - December?

Pfizer is submitting a request to the FDA for authorization, and hopes to start distribution in December. The results have been very promising so far. Do you think enough people will take it? Would you take it?

113 Comments
 

I think most surveys are indicating that 50-60% of the people in the U.S. are willing to take it, and I would definitely be one of them. People are also saying that you need about 75% of people having antibodies for her immunity but I think even if 50% of the population took the vaccine we would be good. I believe a Stanford Study indicated that 9% of the people had been infected in the US and this was back in September. So as long as the government administers the vaccine to people who have not been infected, we would be very close to our goal even by June if what Moderna and Pfizer are promising is accurate. 

 

I think they are distributing it to at risk populations and medical professionals first. I don't expect people like you and I to be getting it until some time in the Spring.

Array
 

By the time it gets to most of us, it will be mostly vetted in the real world.  Assuming that the initial rollouts are successful, I would eventually take it.  

 

financeabc

By the time it gets to most of us, it will be mostly vetted in the real world.  Assuming that the initial rollouts are successful, I would eventually take it.  

Didn’t you say you were suspicious of the vaccine when Trump was in power? Now that it seems like Biden will be in office, have you all of a sudden decided that the vaccine is worth taking?

Array
 
Controversial

IncomingIBDreject

financeabc

By the time it gets to most of us, it will be mostly vetted in the real world.  Assuming that the initial rollouts are successful, I would eventually take it.  

Didn't you say you were suspicious of the vaccine when Trump was in power? Now that it seems like Biden will be in office, have you all of a sudden decided that the vaccine is worth taking?

I was suspicious but in the world of science, when there more data and more information about a topic, opinions change.  With high efficacy rates and a delay for the roll out for the general public until probably the spring, it makes sense for most people to take it.  This is assuming that the initial rollouts go well.  

 

This is such a stupid comparison. Many, many people don’t take the flu vaccine early, in fact it’s only about 40% of adults.... so trying to guilt people into the a new vaccine when most don’t even take one that’s been around to decades is asinine to say the least. Source: https://www.cdc.gov/flu/fluvaxview/coverage-1819estimates.htm

 

You couldn’t pay me a million dollars to take this vaccine. Influenza vaccine efficacy rate hovers around 40% year over year and suddenly I’m supposedly to believe multiple companies have developed a vaccine that has 90%+ efficacy for a “novel” coronavirus. Either the vaccine isn’t that good or the virus is not what they say it is. Either way, I’m out on that pal.

 

wow it's almost like they're different viruses that behave differently you fucking brainlet, how many times did you take the measles vaccine in your life?

To live is to suffer, to survive is to find some meaning in the suffering.
 

Tough guy. Relax with the insults. My point is that I’m not taking a vaccine that has been developed in less than 10 months and is the first of its kind. I don’t see any real benefit for me, considering that I’m a healthy 20 something year old. I already have 99.999997% chance of survival, I’ll take my chances without a vaccine that has been tested on 100 people.

 

This is good news by Pfizer. I hope that enough people do take the vaccine but I will not be one of them. COVID has been considered as the most devastating virus to the world since 1918. HIV is pretty serious but it isn’t so easily contracted. But yet a vaccine has been developed in less than 12 months?(First reported US case was January). At the beginning of the pandemic, a lot of health professionals said vaccines typically take 8-10 years to develop. Now I understand pretty much every company has been working on a vaccine so you expect quicker results but 12 months sounds dubious to me. Once again, I hope it is good and a lot of people take it but I won’t be one of them. I also hope these large companies use their newly found quickness and expertise to tackle some of the other serious viruses with no known cure like HIV, HSV-1 and HSV-2, etc. 

 

Folks, why don’t you just wait until other people take the vaccine. If it appears safe, it would make sense for most people to take it. There is no reason to make a hasty decision now.

 

What I don't get is for decades we have suffered & struggled with all forms of cancer, rheumatoid arthritis, multiple sclerosis, auto-immune diseases etc with very little scientific progress. 

Meanwhile, they seem to have developed a solution for this virus within less than a year?

Not a conspiracist but, wtf am I missing?

 

Some problems are easy to solve while others are hard. Cancer is your own mutated cells becoming diseased and killing yourself. In nature, our body has no real mechanisms to defend against the hundreds of different kinds of cancer that exist. Vaccines, on the other hand, is something we understand well and our body essentially does most of the work for us in the sense that our immune cells can "remember" past infections and naturally defend against future viruses of the same type. Now there's many different kinds of vaccines out there but the most basic kind of vaccine was developed by Edward Jenner more than 250 years ago by injecting heat-killed cowpox viruses into people and they subsequently developed an immunity since their bodies remembered the biomarkers of the dead viruses. 

To live is to suffer, to survive is to find some meaning in the suffering.
 
Most Helpful

You have no clue what you are talking about. The Pfizer phase 3 vaccine trial had *43,000* participants, not 170. 
 

The 170 is total symptomatic infections out of 43k people. Of 170 symptomatic infections, 162 occurred in the placebo group, and 8 in the vaccine group. Hence 95% effective. 
 

People need to do the most basic of research before commenting on this topic. I’m not saying I am an expert or that only experts should comment but just basic understanding is required. 
 

https://www.statnews.com/2020/11/18/pfizer-biontech-covid19-vaccine-fda…

 

The Pfizer vaccine trial had 170 people in it..... that's what the 94.5% efficacy rate is based on. You're going to need a whole lot more data than that for me to trust it.

Typically, more data the better. But what an "appropriate" amount of data is unclear here.. If those 170 people were fully or nearly representative of the general population (age, sex, ethnicity, underlying medical conditions, etc...) then the trial would be trustworthy. If those 170 people were not very diverse (ie. all obese, or all from the same place), then the trial would be untrustworthy. 

In the same regard, you could do a trial on 1 million fat people and have that be much more untrustworthy than a trial on 1000 extremely diverse group of people.

 

MonopolyMoney

I'm not going to take it for a while. Will let the most vulnerable take it before me.

I’m pretty sure you won’t have the option to take it before anyways. 

Array
 

I don't feel that comfortable on side effects as normally patients are monitored for 2yrs after vaccine to make sure there are no long term issues. That said, LT issues will most likely present themselves in the first few months anyway if they exist & other populations (hospital workers, teachers) will be getting it first by which point the study should accumulate more data. So when the general pop gets it, likely Feb at the earliest but maybe as late as the summer we'll have a good idea of hidden risks by then

 

we’re soon to have tens of millions of data points. The fact that people buy coke but are skeptical of this is mind blowing (no pun).

https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2020-11/COV…

In the not so distant future we will be doing tens of millions per month - I’m pretty sure that is sufficient. As for the not knowing the long term side effects; fair I guess but then you’re not going to be able to take it. Why are calculated risks such an issue with COVID all around?

 

The main stream media has been repeatedly trying to paint the vaccines as something wildly dangerous during the Trump administration. Now with Biden soon to take over, you see a split in the media where moderate liberal news outlets (NPR) are encouraging people to take it but more mainstream liberal news outlets are still trying to invoke fear. This is due to the fact imo that far left politicians like Newsom and Lightfoot are enjoying their power and control during COVID and don’t want it to go away. 

Generally speaking, however the mainstream US population sucks at math including basic probability and risk/reward analysis. Common core becoming wimpier over the years is only going to make the issue worse and making our world ranking in math only lower as time progresses.

Array
 

Rerum consequatur hic sunt. Vel recusandae qui hic cumque consequuntur et omnis nam. Quia ab dolore rerum deserunt eaque. Dolores optio quam qui ducimus sint minima placeat. Fuga et placeat ut cum.

Ea pariatur nostrum itaque voluptatem. Velit modi debitis iste non et ad fugiat adipisci. Cumque molestias hic aut sed dicta. Voluptatum accusamus reiciendis ipsum accusantium iusto. Molestiae sequi illum tempore quidem quaerat autem. Inventore architecto ex odio expedita non temporibus corrupti.

Et deleniti et alias ipsa consequatur. Dolorem voluptatum reprehenderit cumque. Assumenda repellendus sunt quae.

Minus omnis magni at eum ut perferendis nulla. Rem consequatur at nulla non. Consequatur blanditiis quo mollitia consequuntur minus eaque. Sequi nihil et et et quasi. Nobis eveniet eum sunt et voluptatem.

Array

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (65) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
DrApeman's picture
DrApeman
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”